Radiation therapy for optic nerve sheath meningioma

Practical Radiation Oncology

Volumn 3, Issue 3, 2013, Pages 223-228

  Brower, Jeffrey V ^a   Amdur, Robert J ^a   Kirwan, Jessica ^a   Mendenhall, William M ^a   Friedman, William ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MENINGIOMA; OPTIC NERVE SHEATH MENINGIOMA; OPTIC NERVE TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY; RETINOPATHY; SURVIVAL; TREATMENT OUTCOME; TUMOR VOLUME; VISUAL DISORDER;

EID: 84879885218     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.06.010     Document Type: Article

References (13)

1. Miller N.R. New concepts in the diagnosis and management of optic nerve sheath meningioma. J Neuroophthalmol 2006, 26:200-208.
2. Dutton J.J. Optic nerve sheath meningiomas. Surv Ophthalmol 1992, 37:167-183.
3. Turbin R.E., Thompson C.R., Kennerdell J.S., Cockerham K.P., Kupersmith M.J. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 2002, 109:890-900.
4. Liu J.K., Forman S., Hershewe G.L., Moorthy C.R., Benzil D.L. Optic nerve sheath meningiomas: visual improvement after stereotactic radiotherapy. Neurosurgery 2002, 50:950-957.
5. Narayan S., Cornblath W.T., Sandler H.M., Elner V., Hayman J.A. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2003, 56:537-543.
6. Saeed P., Blank L., Selva D., et al. Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study. Br J Ophthalmol 2010, 94:564-568.
7. Metellus P., Kapoor S., Kharkar S., et al. Fractionated conformal radiotherapy for management of optic nerve sheath meningiomas: long-term outcomes of tumor control and visual function at a single institution. Int J Radiat Oncol Biol Phys 2011, 80:185-192.
8. Arvold N.D., Lessell S., Bussiere M., et al. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2009, 75:1166-1172.
9. Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC). National Cancer Institute; 2009. Available at: Accessed July 18, 2012. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.
10. Abouaf L., Girard N., Lefort T., et al. Standard-fractionated radiotherapy for optic nerve sheath meningioma: visual outcome is predicted by mean eye dose. Int J Radiat Oncol Biol Phys 2012, 82:1268-1277.
11. Stiebel-Kalish H., Reich E., Gal L., et al. Visual outcome in meningiomas around anterior visual pathways treated with linear accelerator fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82:779-788.
12. Landert M., Baumert B.G., Bosch M.M., Lütolf U.M., Landau K. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J Neuroophthalmol 2005, 25:86-91.
13. Paulsen F., Doerr S., Wilhelm H., Becker G., Bamberg M., Classen J. Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2012, 82:773-778.